| Literature DB >> 22102645 |
Paula N Goering1, David L Streiner, Carol Adair, Tim Aubry, Jayne Barker, Jino Distasio, Stephen W Hwang, Janina Komaroff, Eric Latimer, Julian Somers, Denise M Zabkiewicz.
Abstract
Introduction Housing First is a complex housing and support intervention for homeless individuals with mental health problems. It has a sufficient knowledge base and interest to warrant a test of wide-scale implementation in various settings. This protocol describes the quantitative design of a Canadian five city, $110 million demonstration project and provides the rationale for key scientific decisions. Methods A pragmatic, mixed methods, multi-site field trial of the effectiveness of Housing First in Vancouver, Winnipeg, Toronto, Montreal and Moncton, is randomising approximately 2500 participants, stratified by high and moderate need levels, into intervention and treatment as usual groups. Quantitative outcome measures are being collected over a 2-year period and a qualitative process evaluation is being completed. Primary outcomes are housing stability, social functioning and, for the economic analyses, quality of life. Hierarchical linear modelling is the primary data analytic strategy. Ethics and dissemination Research ethics board approval has been obtained from 11 institutions and a safety and adverse events committee is in place. The results of the multi-site analyses of outcomes at 12 months and 2 years will be reported in a series of core scientific journal papers. Extensive knowledge exchange activities with non-academic audiences will occur throughout the duration of the project. Trial registration number This study has been registered with the International Standard Randomised Control Trial Number Register and assigned ISRCTN42520374.Entities:
Year: 2011 PMID: 22102645 PMCID: PMC3221290 DOI: 10.1136/bmjopen-2011-000323
Source DB: PubMed Journal: BMJ Open ISSN: 2044-6055 Impact factor: 2.692
Figure 1Vancouver study design. CONG, congregate housing and supportive services (site-specific arm); HF+ACT, Housing First and assertive community treatment; HF+ICM, Housing First and intensive case management; TAU, Treatment as usual.
Key outcome and process domains and administration schedule
| Domain | Variables | Instruments |
| Housing | Stability Perceived quality Observer-rated quality | Residential Time-Line Follow-Back Inventory Perceived Housing Quality Scale Purpose developed observer-rated Housing Quality Scale |
| Health status | Mental Physical | Modified Colorado Symptom Index (CSI) Global Assessment of Individual Needs GAIN Substance Problem Scale EQ-5D Visual Analog Scale |
| Functioning including community integration, recovery and vocational attainment | Independent living Response to stress Money management Social Meaningful activity, etc | Multnomah Community Ability Scale (MCAS) Adapted community integrations scales (physical and psychological integration) Recovery Assessment Scale Vocational Time-Line Follow-Back |
| Quality of life | Generic quality of life and health-related quality of life | EQ-5D SF-12 SF-6D Qoli-20 |
| Healthcare, social services and justice system use and costs | For example, emergency room visits, hospital admissions, primary and specialist care visits, social agency visits, etc. Charges, court appearances, nights in jail or remand, etc | Composite checklists of service use and justice system-related events, to be combined with administrative data from several mostly site-specific provincial government sources to which costs will be attached using standard costing methods |
Indicates instruments administered every 3 months; all others are every 6 months, except the Housing Quality Scale which is only at 21 months.
Key features of the experimental intervention
| Housing First model |
Recovery oriented culture Based on consumer choice for all services Only requirements: income paid directly as rent; visited at a minimum once a week for pre-determined periods of follow-up supports Rent supplements in private market: participants pay 30% or less of their income or the shelter portion of welfare Treatment and support services voluntary—clinicians/providers based off site Legal rights to tenancy (no head leases with agency rather than individual) No conditions on housing readiness Program facilitates access to housing stock Apartments are independent living settings primarily in scattered sites Services individualised, including cultural adaptations Reduce the negative consequences of substance use Availability of furniture and possibly maintenance services Tenancy not tied to engagement in treatment |
ACT, assertive community treatment; ICM, intensive case management.
| Instrument and relevant published references | Psychometric information |
Sheehan DV, Lecrubier Y, Harnett-Sheehan K, Lecrubier Y, Sheehan D, Weiller E, Sheehan DV, Lecrubier Y, Harnett-Sheehan K, Amorim P, Lecrubier Y, Weiller E, Description (with information from www.medical-outcomes.com): The MINI is a short, structured diagnostic interview that was developed in 1990 by psychiatrists and clinicians in the United States and Europe for DSM-IV and ICD-10 psychiatric disorders. With an administration time of approximately 15 minutes, the MINI is often used for psychiatric evaluation and outcome tracking in clinical psychopharmacology trials and epidemiological studies. In this study, we will be using the modules for diagnosis of major depressive episodes, suicidality, manic and hypomanic episodes, post-traumatic stress disorder, alcohol dependence/abuse, substance dependence/abuse, psychotic disorders and generalised anxiety disorders. | MINI website “The M.I.N.I. has been validated against the much longer Structure Clinical Interview for DSM diagnoses (SCID-P) in English and French and against the Composite International Diagnostic Interview for ICD-10 (CIDI) in English, French and Arabic. It has also been validated against expert opinion in a large sample in four European countries (France, United Kingdom, Italy and Spain). According to researchers at the National Institute of Mental Health's (NIMH) Division of Clinical and Treatment Research, the M.I.N.I. is a fully validated and more time-efficient alternative to the SCID-P and CIDI.” (Sheehan Validity Concordance of MINI-CR with SCID-P MINI diagnoses characterised by good or very good κ values with only one value (for current drug dependence) below 0.5 Sensitivity 0.70 or greater for all but three diagnoses (dysthymia, obsessive compulsive disorder (OCD) and current drug dependence) Specificities and negative predictive values (NPVs) 0.85 or higher across all diagnoses Positive predictive values (PPVs) 0.75 or higher for major depression, lifetime mania, panic disorder, lifetime agoraphobia, lifetime psychotic disorder, anorexia and post-traumatic stress disorder PPVs 0.60–0.74 for current mania, generalised anxiety disorder (GAD), current agoraphobia, OCD, current alcohol dependence, lifetime drug dependence and bulimia PPVs 0.45–0.59 for dysthymia, current psychotic disorder, lifetime social phobia and current drug dependence Concordance of MINI-CR with CIDI κ Values good or very good for all diagnoses (only simple phobia and GAD below 0.50) Sensitivity 0.70 or greater for all but four diagnoses (panic, agoraphobia, simple phobia, lifetime bulimia) Specificity 0.70 or greater for all NPVs very good (0.88 or higher) PPVs 0.75 or higher for major depression, alcohol and drug dependence, and panic disorder PPVs 0.60–0.74 for lifetime manic episode, agoraphobia and simple phobia PPVs 0.45–0.59 for current manic episode, social phobia and lifetime bulimia PPV poor (0.34) for GAD For psychotic disorders, concordance was very good Reliability Kappas listed by 23 diagnoses Inter-rater kappas all above 0.75 and 70% 0.90 and higher Test-retest kappas 61% of values above 0.75 (one, for current mania, below 0.45) Test-retest was carried out using a second interviewer for the retest. |
Shern DL, Wilson NZ, Saranga Coen A, Boothroyd RA, Chen HJ. The psychometric properties of the Colorado Symptom Index. Conrad KJ, Yagelka JR, Matters MD, Greenwood RM, Schaefer-McDaniel NJ, Winkel G, Description (with information from Greenwood | Reliability In Boothroyd (2008), with a sample of 3874 adult Florida Medicaid respondents, test-retest reliability r=0.71, internal consistency α=0.92 In Conrad Cut-points (Boothroyd, 2008) Using 30 as a clinical cut-off score denoting the need for further psychiatric assessment, sensitivity was 0.76 and specificity was 0.68. Using 30 as a cut-off PPV (proportion of individuals with positive assessment who actually have the illness) was 0.32 and NPV (proportion of individuals with a negative assessment who do not have the illness) was 0.93. A receiver operating characteristic (ROC) curve analysis shows that the CSI is a ‘fair to good’ discriminator of individuals with psychiatric disabilities. Validity Boothroyd (2008) reported that correlation between respondents' CSI scores and the reported need for assistance (ie, functioning) was 0.50, suggesting good convergent validity with SF-12. Conrad |
Dennis ML, Chan Y, Funk RR. Development and validation of the GAIN Short Screener for Internalising, Externalising and Substance Use Disorders and Crime/Violence Problems among adolescents and adults. Dennis ML, White MK, Titus JC, Description (information from GAIN website): The GAIN Substance Problem Scale is a 16-item subscale of the larger Global Appraisal of Individual Needs (GAIN) which is a standardised biopsychosocial instrument that integrates research and clinical assessment for people presenting for substance abuse treatment. The GAIN SPS is composed of 16 recency items (eg ‘When was the last time you…?’): 7 based on DSM-IV criteria for dependence, 4 for abuse, 2 for substance-induced health and psychological problems, and 3 on lower severity symptoms of use (hiding use, people complaining about use, weekly use). Higher scores represent greater severity of drug problems. The scale includes physiological, psychosocial and social criteria, as well as an item on comorbid use with drugs that is likely to exacerbate the other problems. | All info from GAIN Overview from Reliability/validity Internal consistency for Substance Problem Scale (Lifetime) is 0.90. For GAIN-I (full instrument), studies with adults and adolescents have found good reliability in test-retest situations on days of use and symptom counts (r=0.7–0.8), as well as diagnosis (κ=0.5–0.7). Self-reports were consistent (κ=0.5–0.8 range) with parent reports, on-site urine and saliva testing, and laboratory-based EMIT and GC/MS urine testing. Self-reports on the GAIN were found to be consistent with a multi-method estimate based on any self-report or positive urine or saliva test for any drug (κ=0.56), cocaine (κ=0.52), opioids (κ=0.55) and marijuana (κ=0.75), with no one method being superior across all drugs. Using discriminant analysis, the GAIN scales could also reliably predict independent and blind staff psychiatric diagnoses of co-occurring psychiatric disorders including ADHD (κ=1.00), Mood Disorders (κ=0.85), Conduct Disorder/Oppositional Defiant Disorder (κ=0.82), Adjustment Disorder (κ=0.69), or the lack of a non-substance use diagnosis (κ=0.91) and to discriminate the primary other disorders across these conditions (κ=0.65). Cut-points 0 mild/1–9 moderate /10–16 severe |
Barker S, Barron N, McFarland BH, Dickerson FB, Origoni AE, Pater A, Description (modified from MCAS website—www.multnomahscale.com): This 17-item scale was first created in 1983 by community mental health case managers. It measures degree of functional ability through 17 indicators. The indicators are rated on a 5-point scale and are grouped into four sections: Health: Physical, mental and emotional symptoms that interfere with daily functioning (5 indicators) Adaptation: Critical abilities for coping with serious mental illness and surviving in the community (3 indicators) Social skills: How people with psychiatric disabilities interact with others (5 indicators) Behaviour: Personal actions that affect community tenure and positive service outcomes (4 indicators). Anchors and interview probes were developed by Dickerson | Dickerson Inter-rater reliability for MCAS with interview probes The infraclass correlation coefficient (ICC) was 0.96 for the Total Score, 0.91 for the Interference with Functioning subscale, 0.99 for the Adjustment to Living subscale, 0.87 for the Social Competence subscale, and 0.96 for the Behavioural Problems subscale. Barker Inter-rater reliability for the original scale ICC was 0.85 for Total Score, 0.70 for the Interference with Functioning subscale, 0.75 for the Adjustment to Living subscale, 0.75 for the Social Competence subscale, and 0.78 for the Behavioural Problems subscale. Test-retest reliability for the original scale ICC was 0.83 for Total Score, 0.77 for the Interference with Functioning subscale, 0.82 for the Adjustment to Living subscale, 0.71 for the Social Competence subscale, and 0.70 for the Behavioural Problems subscale. Cronbach's α was 0.90, suggesting good internal consistency. Validity 17 MCAS items were compared with ‘criterion’ variables related to state mental hospital use and were found to correlate highly with these variables. Found that the instrument is predictive of subsequent state and local hospital admissions (instrument has substantial p<0.001 prospective predictive validity—χ2 test for trend >6.05 with one degree of freedom, p=0.1) Cut-points (excerpt from Toronto site proposal) “Barker |
The EuroQol Group. EuroQol-a new facility for the measurement of health-related quality of life. Brooks R. EuroQol: the current state of play. Lamers LM, Bouwmans CAM, van Straten A, Description (with information from EQ-5D user guide): EQ-5D is a self-administered standardised measure of health status developed by the EuroQoL Group in order to provide a simple, generic measure of health for clinical and economic appraisal. It provides a simple descriptive profile and single index value for health status. The EQ-5D descriptive system has five dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/depression. Each dimension has three levels: no problems, some problems and severe problems. The visual analogue scale records the respondent's self-rated health on a vertical, visual analogue scale where endpoints are labelled ‘best imaginable health state’ and ‘worst imaginable health state’. This information can be used as a quantitative measure of health outcome as judged by the individual respondents. | Extensive general psychometric information is available at The information most relevant to our study is from Lamers Utilities This was a Dutch multi-site randomised trial of 616 patients with mood and/or anxiety disorders. EQ-5D and SF-6D utilities differed significantly between patients of adjacent severity groups. Mean utilities increased from 0.51 at baseline to 0.68 at 1.5-year follow-up for EQ-5D and from 0.58 to 0.70 for SF-6D. For all severity subgroups, the mean change in EQ-5D and SF-6D utilities was statistically significant. Standardised response means were higher for SF-6D utilities. Both EQ-5D and SF-6D discriminated between severity subgroups and captured improvements in health over time, but EQ-5D resulted in larger health gains and lower cost-utility ratios, especially for the subgroup with the highest severity of mental illness. |
Ware JE, Kosinski M, Keller SD. A 12-Item Short Form Health Survey: construction of scales and preliminary tests of reliability and validity. Larson CO. Use of the SF-12 to measure the health of homeless persons. Lamers LM, Bouwmans CAM, van Straten A, Description (with information from an Australian Health Outcomes Collaboration instrument review— | Extensive general psychometric information is available at Information of relevance to our study is from Larson (2002). This study evaluated construct validity of the SF-12 among users of a homeless day shelter. The study compares SF-12 scores from a sample of homeless persons to scores from a sample of the general population. Reliability The internal consistency estimates of summary scores were calculated using Cronbach's α. Within the homeless sample these were found to be 0.82 for physical health and 0.79 for mental health. Estimates for the general population were found to be 0.78 for physical health and 0.73 for mental health. Validity Construct validity was assessed by the method of extreme groups where multivariate analysis of variance determined if SF-12 summary scores varied for individuals who differed in self-reported clinical symptoms and medical conditions. Four to 10 point differences in physical health (PCS-12) and 5–11 point differences in mental health (MCS-12) were found between those who reported acute symptoms and medical conditions and those who did not. A 13 point difference in PCS-12 scores and a 7–16 point difference in MCS-12 scores were found for those who reported none or few to several symptoms or conditions. Convergent validity was assessed by correlating SF-12 summary scores with the subscales. Summary scores and subscales yielded satisfactory convergent validity coefficients that ranged from 0.62 to 0.88. Ware |
Lehman AF. Measures of quality of life among persons with severe and persistent mental disorders. Uttaro T, Lehman A. Graded response modelling of the Quality of Life Interview. Lançon C, Auquier P, Toumi M, Description (with information from Lehman, 1996): The original scale was designed to assess the quality of life of people with severe and persistent mental illness. It is a structured self-report interview, conducted by a trained non-clinical interviewer, and elicits participants' ratings of their quality of life. There are 7 subjective scales (living situation, everyday activities, family, social relationships, finances, safety and satisfaction with life in general) and 4 objective scales (everyday activities, enough money, family contacts and contacts with friends). The 20-item version was developed by Uttaro | Lancon Scores for nine subjective dimensions were uniformly distributed. The discrimination index ranged from 0.87 to 0.96. Objective items had discrimination indices varying from 0.79 to 0.94. Item scores were highly correlated with scores on the subscale to which that item contributes (0.6 upwards). Lehman (1996) Internal consistency scores (using Cronbach's α) for the original scale range from 0.79 to 0.88 for the subjective scales, and from 0.44 to 0.82 for the objective scales. Subjective scale α coefficients: living situation (0.83), everyday activities (0.83), family (0.88), social relationships (0.71), finances (0.84), safety (0.84) and satisfaction with life in general (0.74). Objective scale α coefficients: everyday activities (0.62), enough money (0.78), family contacts (0.69) and contacts with friends (0.72). Uttaro 20-Item version was derived using item-response theory. Internal consistency was retained. |
Giffort D, Schmook A, Woody C, Corrigan PW, Giffort D, Rashid F, Corrigan PW, Salzer M, Ralph R, | Corrigan Alphas for factors ranged from 0.74 to 0.87: personal confidence and hope (0.87), willingness to ask for help (0.84), goal and success orientation (0.82), reliance on others (0.74), and no domination by symptoms (0.74). Reliability Cronbach's α 0.93 in initial testing. Respondents in initial testing completed the scale twice within 14 days. Pearson Product Moment Correlation was r=0.88 (n=35). Validity RAS total score positively correlated with other measures: Rosenberg Self-Esteem Scale (r=0.55), Empowerment Scale Self-orientation (0.71), Social Support Questionnaire—short version (0.48), Quality of Life Interview—subjective component (0.62), Brief Psychiatric Rating Scale—expanded version (0.44). |
Tsemberis S, McHugo G, Williams V, | Test-retest reliability high, with coefficients ranging from 0.80 to 0.91. Concurrent validity good, assessed by associations between agency and self-reports, with coefficients ranging from 0.84 to 0.92. |
Latimer EA, Lecomte T, Becker DR, | The VTLFB was adapted for our study from an instrument developed by Dr Eric Latimer (Montreal site lead investigator) for earlier studies of the outcomes of a vocational intervention—Individual Placement and Supports (IPS) (see reference). |
Tsemberis S, Rogers ES, Rodis E, Toro PA, Bellavia CW, Daeschler CV, | For this instrument relevant items were selected from existing questionnaires for which little psychometric information is available. Some items were pre-tested in our study population. |
Ambulatory Health Care Record (AHCR) Guerriere DN, Ungar WJ, Corey M, Utilisation and Cost Inventory (UAC-I) Kashner MT, Stensland MD, Lind L, Cornell Service Index (CSI) Sirey J, Beyers BS, Teresi JA, Health Service Utilisation Inventory Browne GB, Arpin K, Corey P, Utilisation of Hospital and Community Services Form Forchuk C, Brown SA, Schofield R, Client Socio-Demographic and Service Receipt Inventory (CSSRI) Chishom MR, Knapp MRJ, Knudsen HC, Service Use Questionnaire for the Continuity of Mental Health Services (COMHS) Study of Alberta Adair CE, McDougall GM, Mitton CR, | The HSJSU was developed specifically for this study because no single health services use questionnaire was identified in the literature that was suitable for our research questions and study population. We used seven existing instruments (as per references) to ensure comprehensive coverage of items and then added items that were relatively unique to our study population (eg, food bank service use). Some of the service use items for which recall was anticipated to be a problem were pre-tested and piloted for the study. |
Canadian Community Health Survey (CCHS) 2008 Questionnaire. Statistics Canada ( Khandor E, Mason, K. Hwang SW, Ueng JJM, Chiu S, | These items were developed by the Toronto site team and are based on the sources in the references. |
Segal SP, Aviram U. Aubry T, Myner J. Community integration and quality of life: a comparison of persons with psychiatric disabilities in housing programs and community residents who are neighbors. Chavis DM, Hogge JH, McMillan DW, | Three sources of items (as referenced) for the concept of community integration were extensively pre-tested in our study population, given that many were not relevant or applicable. Little psychometric information was available for the original scales. |
Note that the psychometric values reported here reflect the relevant literature in late 2008/early 2009.